Quanterix Corporation
Quanterix Corporation (QTRX) Financial Performance & Income Statement Overview
Explore the financials of Quanterix Corporation (QTRX), including yearly and quarterly data on income, cash flow, and balance sheets.
Quanterix Corporation (QTRX) Income Statement & Financial Overview
Explore comprehensive income reports for Quanterix Corporation QTRX, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $30.33M | $35.16M | $35.41M | $34.38M |
| Cost of Revenue | $13.92M | $12.99M | $15.66M | $14.32M |
| Gross Profit | $16.41M | $22.17M | $19.75M | $20.06M |
| Gross Profit Ratio | $0.54 | $0.63 | $0.56 | $0.58 |
| R&D Expenses | $10.04M | $8.07M | $8.10M | $8.10M |
| SG&A Expenses | $32.46M | $28.87M | $23.80M | $25.06M |
| Operating Expenses | $42.49M | $34.44M | $31.50M | $32.91M |
| Total Costs & Expenses | $56.41M | $46.34M | $47.16M | $47.49M |
| Interest Income | $3.27M | $3.49M | $3.54M | $3.68M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $3.62M | $776000.00 | $2.44M |
| EBITDA | -$26.37M | -$11.15M | -$10.97M | -$10.67M |
| EBITDA Ratio | -$0.87 | -$0.32 | -$0.31 | -$0.31 |
| Operating Income | -$26.37M | -$14.77M | -$11.75M | -$13.11M |
| Operating Income Ratio | -$0.87 | -$0.42 | -$0.33 | -$0.38 |
| Other Income/Expenses (Net) | $2.95M | $3.13M | $3.54M | $3.67M |
| Income Before Tax | -$23.42M | -$11.64M | -$8.21M | -$9.44M |
| Income Before Tax Ratio | -$0.77 | -$0.33 | -$0.23 | -$0.27 |
| Income Tax Expense | $2.91M | -$8000.00 | $145000.00 | $37000.00 |
| Net Income | -$20.50M | -$11.63M | -$8.35M | -$9.47M |
| Net Income Ratio | -$0.68 | -$0.33 | -$0.24 | -$0.28 |
| EPS | -$0.53 | -$0.30 | -$0.22 | -$0.25 |
| Diluted EPS | -$0.53 | -$0.30 | -$0.22 | -$0.25 |
| Weighted Avg Shares Outstanding | $38.72M | $38.55M | $38.45M | $38.34M |
| Weighted Avg Shares Outstanding (Diluted) | $38.72M | $38.55M | $38.45M | $38.34M |
The company's financials show resilient growth, with revenue advancing from $34.38M in Q2 2024 to $30.33M in Q1 2025. Gross profit remained healthy with margins at 54% in Q1 2025 compared to 58% in Q2 2024. Operating income hit -$26.37M last quarter, sustaining a consistent -87% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$26.37M. Net income dropped to -$20.50M, while earnings per share reached -$0.53. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan